Oragenics, Inc. (OGEN) vs Windtree Therapeutics, Inc. (WINT)

Oragenics, Inc. and Windtree Therapeutics, Inc. are both Biotechnology companies. Oragenics, Inc. and Windtree Therapeutics, Inc. are of similar size ($2.4M and $2.3M). Windtree Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Windtree Therapeutics, Inc. grew revenue faster over the last twelve months: −68.4% against −75.1%. Across the 13 metrics below, Windtree Therapeutics, Inc. leads on 8 and Oragenics, Inc. on 5.

Valuation

Metric OGEN WINT Biotechnology median
P/E 0.44 n/m 7.88
P/S 17.54 n/m 11.47
P/B 0.59 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.16 n/m 0.74
EV/Sales (13.16) 63.80 10.73
Earnings yield 228.10% 0.00% (28.84%)
Free cash flow yield (469.27%) 0.00% (23.03%)

Profitability

Metric OGEN WINT Biotechnology median
Gross margin 19.89% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,307.07%) 1,356.23% (57.72%)
Return on assets (264.23%) (210.34%) (49.22%)
Return on invested capital 0.00% (386.34%) 0.00%

Growth

Metric OGEN WINT Biotechnology median
Revenue growth (TTM) (75.08%) (68.35%) 5.64%
EPS growth (last fiscal year) 90.51% 97.79% —
Revenue growth, 5-year CAGR (50.98%) (41.28%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OGEN WINT Biotechnology median
Debt to equity 0.00 (1.48) 0.00
Current ratio 3.01 0.33 4.73
Net debt to EBITDA 0.98 0.03 0.96

Dividend

Metric OGEN WINT Biotechnology median
Dividend yield — 4.38% 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric OGEN WINT Biotechnology median
Market cap 2.27m 2.35m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack